Certara, Inc. (CERT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Certara, Inc. (CERT) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Certara to Participate in Upcoming Investor Conferences
Craig-Hallum Maintains Hold on Certara, Lowers Price Target to $8
BMO Capital Maintains Market Perform on Certara, Lowers Price Target to $6
Barclays Maintains Equal-Weight on Certara, Lowers Price Target to $6.5
Stephens & Co. Maintains Overweight on Certara, Lowers Price Target to $9
Morgan Stanley Maintains Equal-Weight on Certara, Lowers Price Target to $10
Baird Maintains Neutral on Certara, Lowers Price Target to $6
Certara Inc (CERT) Q1 2026 Earnings Call Highlights: Navigating Modest Growth and Strategic ...
Certara (CERT) Q1 2026 Earnings Call Transcript
Certara (CERT) Shares Slide After Weak Full-Year Guidance Overshadows Revenue Beat
Certara Q1 Earnings Call Highlights
Certara, Inc. (CERT) Q1 2026 Earnings Call Transcript
Certara (NASDAQ:CERT) Q1 2026: Software Shines, but Divestiture and Mixed Metrics Weigh on Shares
Certara, Inc. (CERT) Q1 Earnings Miss Estimates
Certara Reports First Quarter 2026 Financial Results
Certara, Inc. 2026 Q1 - Results - Earnings Call Presentation
Certara Lowers FY2026 Adj EPS Guidance from $0.44-$0.48 to $0.35-$0.41 vs $0.45 Est; Lowers FY2026 Sales Guidance from $418.800M-$435.552M to $395.000M-$405.000M vs $425.854M Est
Certara Q1 Adj. EPS $0.09 Misses $0.11 Estimate, Sales $106.900M Beat $106.095M Estimate
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.